Scilex Holding Co (SCLXW) fundamentals chart

SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.04−0.00 (-1.53%)

Close on Oct 30, 2026Market cap $17.50MP/E –Yield –

Fundamental chart

Pick a measure to chart its full history

$30.25MFY2025, +5.1% a year since FY2020

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SCLXW.

Revenue growth-28.5% · median 128.5%

Gross margin161.1% · median 78.6%

Operating margin-1136.4% · median -311.6%

Net margin-1469.8% · median -259.4%

Advertisement
300 × 250